Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer

British Journal of Cancer

Volumn 111, Issue 11, 2014, Pages 2082-2090

  Ueno, H ^a   Shinto, E ^a   Kajiwara, Y ^a   Fukazawa, S ^a   Shimazaki, H ^a   Yamamoto, J ^a   Hase, K ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

cancer microenvironment; cancer associated fibroblasts; colorectal cancer; dedifferentiation; desmoplastic reaction; epithelial mesenchymal transition

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; UFT;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CELL DEDIFFERENTIATION; COLORECTAL CANCER; DISEASE FREE SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STRATIFICATION; TUMOR DIFFERENTIATION; TUMOR MICROENVIRONMENT; VERY ELDERLY; ADOLESCENT; COLORECTAL TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL DEDIFFERENTIATION; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 84927178194     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.509     Document Type: Article

References (37)

1. Adam R, Bhangui P, Poston G, Mirza D, Nuzzo G, Barroso E, Ijzermans J, Hubert C, Ruers T, Capussotti L, Ouellet J-F, Laurent C, Cugat E, Colombo PE, Milicevic M (2010) Is perioperative chemotherapy useful for soloitary, metachronous, colorectal liver metastases? Ann Surg 252: 774-787.
2. Akaike H (1973) Information theory and an extension of the maximum likelihood principle. 2nd International Symposium on Information Theory. Akademia Kiado: Budapest.
3. Allen M, Jones L (2011) Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 223: 162-176.
4. Ashley N (2013) Regulation of intestinal cancer stem cells. Cancer Lett 38: 120-126.
5. Barresi V, Bonetti LR, Branca G, Gregorio CD, de Leon MP, Tuccari G (2012) Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. Virchows Arch 461: 621-628.
6. Beppu T, Sakamoto Y, Hasegawa K, Honda G, Tanaka K, Kotera Y, Nitta H, Yoshidome H, Hatano E, Ueno M, Takamura H, Baba H, Kosuge T, Kokudo N, Takahashi K, Endo I, Wakabayashi G, Miyazaki M, Uemoto S, Ohta T, Kikuchi K, Yamaue H, Yamamoto M, Takada T (2012) A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 19: 72-84.
7. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T (2005) Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749.
8. Chen Y-G, Liu X, Wang X-S (2013) Classifying the stage IV colorectal cancer: prognostic impact of radical resection for colorectal liver metastases and proposal for a new staging system. Cell Biochem Biophys 67: 1445-1449.
9. Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL (2010) Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systematic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 17: 492-501.
10. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Futher of TNM. Ann Surg Oncol 17: 1471-1474.
11. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Sttasberg SM (2005) Effect of steathepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200: 845-853.
12. Fodde R, Brabletz T (2007) Wnt/b-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19: 150-158.
13. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
14. Hlubek F, Brabletz T, Budczies J, Pfeiffer S, Jung A, Kirchner T (2007) Heterogeneous expression of Wnt/b-catenin target genes within colorectal cancer. Int J Cancer 121: 1941-1948.
15. Japanese Society for Cancer of the Colon and Rectum (2009) Japanese Classification of Colorectal Carcinoma (2nd English edn). Kanehara & Co., Ltd.: Tokyo, Japan.
16. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252.
17. Jung A, Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, Niedobitek C, Brabletz T, Kirchner T (2001) The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear b-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 159: 1613-1617.
18. Kajiwara Y, Ueno H, Hashiguchi Y, Shinto E, Shimazaki H, Mochizuki H, Hase K (2011a) Expression of L1 cell adhesion molecule and morphologic features as the invasive front of colorectal cancer. Am J Clin Pathol 136: 138-144.
19. Kajiwara Y, Ueno H, Hashiguchi Y, Shinto E, Shimazaki H, Mochizuki H, Hase K (2011b) Heterogeneity of metalloproteinase expression in colorectal cancer-relation of molecular findings to basic morphology. Anticancer Res 31: 1567-1576.
20. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
21. Karagiannis GS, Poutahidis T, Erdman SE, Kirsch R, Riddell RH, Diamandis EP (2012) Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol Cancer Res 10: 1403-1418.
22. Kobayashi H, Kotake K, Sugihara K (2013) Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate? Int J Clin Oncol 18: 696-703.
23. Lee W-S, Kang M, Bae J-H, Lee J-I, Ha SY (2013) Clinical impact of tumorinfiltrating lymphocytes for survival in curatively resected stage IV colon cancer with isolated liver or lung metastasis. Ann Surg Oncol 20: 697-702.
24. McAllister SS, Weinberg RA (2010) Tumor-host interactions: a far-reaching relationship. J Clin Oncol 28: 4022-4028.
25. Medema JP, Vermeulen L (2011) Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 474: 318-326.
26. Mesker WE, Junggeburt JMC, Szuhai K, de Heer P, Morreau H, Tanke HJ, Tollenaar AEM (2007) The carcionma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol 29: 387-398.
27. National Comprehensive Cancer Network (2014) NCCN clinical practice guidelines in oncology-colon cancer (version 3. 2014) http://www.nccn.org/professionals/physician-gls/pdf/colon.pdf, accessed 20 March 2014.
28. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Cutsem EV, Scheithauer W, Gruenberger T (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371: 1007-1016.
29. Sobin L, Gospodarowicz M, Wittekind C (eds) (2009) TNM Classification of Malignant Tumours (7th edn). Wiley-Blackwell: West Sussex, U.K.
30. Stillwell AP, Ho Y-H, Veitch C (2011) Systematic review of prognostic factors related to overall survival in patients with stage IV colorectal cancer and unresectable metastases. World J Surg 35: 684-692.
31. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
32. Ueno H, Hase K, Hashiguchi Y, Shimazaki H, Tanaka M, Miyake O, Masaki T, Shimada Y, Kinugasa Y, Mori Y, Kishimoto M, Kameoka S, Sato Y, Matsuda K, Nakadoi K, Shinto E, Nakamura T, Sugihara K (2014) Site-specific tumor grading system in colorectal cancer: multicenter pathological review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol 38: 197-204.
33. Ueno H, Jones A, Jass JR, Talbot IC (2002) Clinicopathological significance of the 'keloid-like' collagen and myxoid stroma in adnvaced rectal cancer. Histopathology 40: 327-334.
34. Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC (2004) Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut 53: 581-586.
35. Ueno H, Shimazaki H, Shinto E, Hashiguchi Y, Nakanishi K, Maekawa K, Katsurada Y, Nakamura T, Mochizuki H, Yamamoto J, Hase K (2012) New criteria for histologic grading of colorectal cancer. Am J Surg Pathol 36: 193-201.
36. West NP, Dattani M, McShane P, Hutchins G, Grabsch J, Mueller W, Treanor D, Quirke P, Grabsch H (2010) The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer 102: 1519-1523.
37. Wolpin BM, Mayer RJ (2008) Reviews in basic and clinical gastroenterology. Gastroenterology 134: 1296-1310.